Erck Stanley C

Average Profitability
234.14%
Insider Buys Quantity
13
Insider Buys Sum
$977,699.52
Insider Sells Quantity
15
Insider Sells Sum
$61.27M

Insider Activity of Erck Stanley C

According to the SEC Form 4 filings, Erck Stanley C, being in a position of

  1. director at MaxCyte, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 95378 shares for $370,407,
    over all time since 2024-09-03, has bought 0 shares, and sold 95378 shares for $370,407.

The largest purchase of all time was on 2018-05-14 and amounted to 200000 shares of Novavax, Inc. for $329,240.

The largest sale of all time was on 2021-07-02 and amounted to 52559 shares of Novavax, Inc. for $11.35M.

Biography of Erck Stanley C

No biography is available at this moment.

2024-10-02SaleMaxCyte, Inc.
MXCT
director
21,607
0.0196%
$3.71$80,162-2.54%
2024-10-01SaleMaxCyte, Inc.
MXCT
director
26,082
0.0241%
$3.78$98,590-0.81%
2024-09-04SaleMaxCyte, Inc.
MXCT
director
29,767
0.0288%
$3.97$118,175+1.54%
2024-09-03SaleMaxCyte, Inc.
MXCT
director
17,922
0.0171%
$4.10$73,480-3.18%
2021-10-04SaleNovavax, Inc.
NVAX
President and CEO
42,829
0.0559%
$176.15$7.54M-59.71%
2021-10-01SaleNovavax, Inc.
NVAX
President and CEO
49,000
0.0624%
$175.10$8.58M-59.92%
2021-07-02SaleNovavax, Inc.
NVAX
President and CEO
52,559
0.0699%
$215.89$11.35M-37.69%
2021-07-01SaleNovavax, Inc.
NVAX
President and CEO
52,620
0.0695%
$212.88$11.2M-36.92%
2020-11-16SaleNovavax, Inc.
NVAX
President and CEO
104,632
0.1592%
$90.65$9.49M+101.24%
2020-10-01SaleNovavax, Inc.
NVAX
President and CEO
4
<0.0001%
$108.56$434+72.98%
2020-09-30SaleNovavax, Inc.
NVAX
President and CEO
24,462
0.0379%
$110.30$2.7M+67.19%
2020-09-29SaleNovavax, Inc.
NVAX
President and CEO
8,224
0.0134%
$108.41$891,563+67.51%
2020-09-28SaleNovavax, Inc.
NVAX
President and CEO
50,000.02
0.0806%
$110.30$5.51M+62.15%
2018-05-14PurchaseNovavax, Inc.
NVAX
President and CEO
200,000
0.0518%
$1.65$329,240-4.73%
2017-11-09PurchaseNovavax, Inc.
NVAX
President and CEO
200,000
0.0684%
$1.13$226,100+43.36%
2017-05-11PurchaseNovavax, Inc.
NVAX
President and CEO
50,000
0.016%
$0.84$41,980+27.96%
2016-03-31SaleNovavax, Inc.
NVAX
President and CEO
453,538
0.1683%
$5.18$2.35M-61.24%
2016-03-30SaleNovavax, Inc.
NVAX
President and CEO
396,018
0.0923%
$3.24$1.28M-60.89%
2016-01-31PurchaseNovavax, Inc.
NVAX
CEO and President
4,144
0.0013%
$4.38$18,151
2015-07-31PurchaseNovavax, Inc.
NVAX
CEO and President
6,414
0.0004%
$2.28$14,624-42.95%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.